Merrill Lynch Greater Europe IT PLC
20 February 2006
MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc
All information is at 31 January 2006 and unaudited.
Performance at month end with net income reinvested
One Three One Since launch
Month Months Year (20Sep04)
Net asset value 4.4% 17.6% 37.7% 53.3%
Share price 7.7% 20.1% 43.2% 51.4%
FTSE World Europe ex UK 3.1% 13.1% 29.0% 41.8%
Sources: Merrill Lynch Investment Managers and Datastream.
At month end
Net asset value: 151.51p Includes net revenue return of 0.10p
Share price: 149.50p
Discount to NAV: 1.3%
Gearing: 10.0%
Net yield: 1.1%
Total assets: £222.0m
Ordinary shares in issue: 132,955,096
Benchmark
Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%)
Financials 36.5 33.5 Germany 21.4
Industrials 11.1 10.5 France 17.2
Oil & Gas 10.9 6.7 Switzerland 12.2
Utilities 8.0 6.7 Italy 9.8
Telecoms 7.2 6.5 Netherlands 5.1
Healthcare 6.5 8.4 Scandinavia 5.0
Consumer Services 6.1 5.4 Russia 4.9
Basic Materials 5.7 5.0 Sweden 4.8
Consumer Goods 4.4 12.4 Spain 4.4
Technology 4.1 4.9 Belgium 4.1
Other Investments 2.0 - Israel 4.1
Net Current Liabilities (2.5) - Ireland 4.0
Poland 1.8
Greece 1.6
Turkey 0.9
Austria 0.1
Other Countries 1.1
Net Current Liabilities (2.5)
----- ----- -----
100.0 100.0 100.0
----- ----- -----
Ten Largest Equity Investments
Company Country of Risk
Allianz Germany
BBVA Spain
Credit Suisse Switzerland
Fortum Finland
Ing Groep Netherlands
Novartis Switzerland
RWE Germany
Siemens Germany
Total France
UBS Switzerland
Unicredito Italiano Italy
Commenting on the markets, James Macmillan, representing the Investment Manager
noted:
European equity markets continued their upward trend in January, reaching fresh
four year highs. The FTSE World Europe ex UK and MSCI Emerging Europe returned
3.1% and 10.7% in sterling terms, respectively. Investors focused on generally
upbeat data on economic growth in Europe and largely ignored external factors
such as rising energy prices and another 0.25% increase in the US Federal Funds
target rate to 4.5%. Indications that the European Central Bank is likely to
increase its official interest rates by 0.25% in March were generally shrugged
off as a non-event. European corporate earnings reported in recent months
continued to be slightly ahead of forecasts, albeit with some disappointments
mainly in consumer related sectors.
The Company's NAV returned 4.4% during January outperforming the reference index
by 1.3%. The contribution from the emerging Europe region continued to have a
positive effect with strong stock selection in Poland and Russia. The use of
flexible gearing was also beneficial and the Company benefited from being
positively geared in a rising market.
During January the Company benefited from strong stock selection across a range
of sectors which included energy, diversified financials, telecoms, utilities
and healthcare. Individual stocks to have a positive contribution were exchange
provider Deutsche Boerse, utility Fortum, oilfield services company Geophysique,
medical company Fresenuis and logistics provider Deutsche Post.
The stocks which detracted from performance were low cost airline Ryan Air (-7%)
falling on lower passenger volume data, and pharmaceutical company AstraZeneca
(-4%) due to market concerns that the loss of US patent protection for it's top
selling heart drug, Toprol, would negatively impact earnings.
During the month the Company increased its exposure to the telecoms and
automobile sector through the purchase of Telefonica and Renault. This was
funded by selling German steelmaker Salzgitter and Hungarian pharmaceutical
Egis, both which after strong performance reached our target prices.
The Company continues to have a bias towards the financials, mainly through
banks but also diversified financials and insurance. Other key sector weights
include utilities and energy. Exposure to Emerging Europe decreased slightly
during the month to finish at 11.7%. The Company ended the month with a net
market exposure of 110%.
Recent surveys suggest that business confidence is rising strongly in
Continental Europe signalling that economic growth is accelerating in 2006.
Companies are benefiting from strong overseas demand particularly in the United
States and Asia. However, concerns still remain that the continued high oil
price and a slowdown in global economic growth levels may impact profit margins.
Despite some bright spots in the periphery countries such as Greece, Ireland,
Norway, Spain and Sweden, domestic demand across much of Continental Europe
remains weak as households suffer from high unemployment and weak purchasing
power. The consensus view is that economic growth across much of Europe will
not exceed its potential rate for the foreseeable future. Nevertheless most
observers expect the European Central Bank to raise interest rates further in
the coming months to counter the threat of higher inflation. Meanwhile the
operating performance of European listed companies remains highly satisfactory
as a result of strenuous cost control and restructuring efforts. We expect 2006
to be another year of strong positive returns from European equity markets.
Latest information is available by typing www.mlim.co.uk/its on the internet,
'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal).
20 February 2006
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.